155 related articles for article (PubMed ID: 17936216)
21. Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.
Petrarca A; Rigacci L; Caini P; Colagrande S; Romagnoli P; Vizzutti F; Arena U; Giannini C; Monti M; Montalto P; Matucci-Cerinic M; Bosi A; Laffi G; Zignego AL
Blood; 2010 Jul; 116(3):335-42. PubMed ID: 20308604
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.
Colantuono S; Mitrevski M; Yang B; Tola J; Carlesimo M; De Sanctis GM; Fiorilli M; Casato M; Visentini M
Clin Rheumatol; 2017 Mar; 36(3):617-623. PubMed ID: 28111716
[TBL] [Abstract][Full Text] [Related]
23. Rituximab in mixed cryoglobulinemia: increased experience and perspectives.
De Vita S; Quartuccio L; Fabris M
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S122-8. PubMed ID: 17936213
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients.
Terrier B; Saadoun D; Sène D; Sellam J; Pérard L; Coppéré B; Karras A; Blanc F; Buchler M; Plaisier E; Ghillani P; Rosenzwajg M; Cacoub P
Arthritis Rheum; 2009 Aug; 60(8):2531-40. PubMed ID: 19644879
[TBL] [Abstract][Full Text] [Related]
25. Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: rapid response to treatment with rituximab.
Uppal R; Charles E; Lake-Bakaar G
J Clin Virol; 2010 Jan; 47(1):69-71. PubMed ID: 19892591
[TBL] [Abstract][Full Text] [Related]
26. [Treatment with rituximab in a patient with mononeuritis multiplex asocciated to hepatitis C infection with mixed cryoglobulinemia].
Ivorra J; Muñoz S; Román-Ivorra J; Beltrán E
Med Clin (Barc); 2009 Mar; 132(11):444-5. PubMed ID: 19268328
[No Abstract] [Full Text] [Related]
27. Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis.
Saadoun D; Resche-Rigon M; Sene D; Perard L; Karras A; Cacoub P
Ann Rheum Dis; 2008 Oct; 67(10):1431-6. PubMed ID: 18178690
[TBL] [Abstract][Full Text] [Related]
28. Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach.
Perez-Alamino R; Espinoza LR
Curr Rheumatol Rep; 2014 May; 16(5):420. PubMed ID: 24647999
[TBL] [Abstract][Full Text] [Related]
29. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients.
Basse G; Ribes D; Kamar N; Mehrenberger M; Esposito L; Guitard J; Lavayssière L; Oksman F; Durand D; Rostaing L
Transplantation; 2005 Dec; 80(11):1560-4. PubMed ID: 16371926
[TBL] [Abstract][Full Text] [Related]
30. Rituximab as a therapeutic tool in severe mixed cryoglobulinemia.
Roccatello D; Baldovino S; Rossi D; Giachino O; Mansouri M; Naretto C; Di Simone D; Francica S; Cavallo R; Alpa M; Napoli F; Sena LM
Clin Rev Allergy Immunol; 2008 Feb; 34(1):111-7. PubMed ID: 18270864
[TBL] [Abstract][Full Text] [Related]
31. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.
Sneller MC; Hu Z; Langford CA
Arthritis Rheum; 2012 Mar; 64(3):835-42. PubMed ID: 22147444
[TBL] [Abstract][Full Text] [Related]
32. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
Shaikh A; Habermann TM; Fidler ME; Kumar S; Leung N
Clin Exp Nephrol; 2008 Aug; 12(4):292-295. PubMed ID: 18288560
[TBL] [Abstract][Full Text] [Related]
33. Rituximab in cryoglobulinaemic vasculitis, evidence for its effectivity: a case report and review of literature.
Wink F; Houtman PM; Jansen TL
Clin Rheumatol; 2011 Feb; 30(2):293-300. PubMed ID: 21053035
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of rituximab in severe and mild abdominal vasculitis in the course of mixed cryoglobulinemia.
Quartuccio L; Petrarca A; Mansutti E; Pieroni S; Calcabrini L; Avellini C; Zignego A; De Vita S
Clin Exp Rheumatol; 2010; 28(1 Suppl 57):84-7. PubMed ID: 20412709
[TBL] [Abstract][Full Text] [Related]
35. Treatment of type II cryoglobulinemia associated with hepatitis C with rituximab.
Pekow J; Chung RT
J Clin Gastroenterol; 2006; 40(5):450. PubMed ID: 16721231
[No Abstract] [Full Text] [Related]
36. Rituximab induces remission in refractory HCV associated cryoglobulinaemic vasculitis.
Lamprecht P; Lerin-Lozano C; Merz H; Dennin RH; Gause A; Voswinkel J; Peters SO; Gutzeit O; Arlt AC; Solbach W; Gross WL
Ann Rheum Dis; 2003 Dec; 62(12):1230-3. PubMed ID: 14644867
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.
Sansonno D; De Re V; Lauletta G; Tucci FA; Boiocchi M; Dammacco F
Blood; 2003 May; 101(10):3818-26. PubMed ID: 12506023
[TBL] [Abstract][Full Text] [Related]
38. Chronic hepatitis C: a systemic disease.
Mazzaro C
Minerva Med; 2021 Apr; 112(2):159-161. PubMed ID: 33555167
[No Abstract] [Full Text] [Related]
39. Rituximab plus belimumab in non-infectious refractory cryoglobulinemia vasculitis: A pilot study.
Saadoun D; Ghembaza A; Riviere S; Mekinian A; Boutemy J; Leroux G; Domont F; Maillard H; Vautier M; Cacoub P
J Autoimmun; 2021 Jan; 116():102577. PubMed ID: 33248866
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of rituximab in type II mixed cryoglobulinemia.
Zaja F; De Vita S; Mazzaro C; Sacco S; Damiani D; De Marchi G; Michelutti A; Baccarani M; Fanin R; Ferraccioli G
Blood; 2003 May; 101(10):3827-34. PubMed ID: 12560225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
